Delivery Order SPE2DB22D2206-SPE2DB24FKH06
Award Date
9/12/24
Potential Completion Date
10/3/24
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $9,367.94 fixed-price contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to support military treatment facilities and programs. The contract has an ultimate completion date of August 8, 2024 and was awarded on July 18, 2024. Amerisourcebergen, a major pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $7,036.80, is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. It has an ultimate completion date of August 6, 2024. The contract is not subject to any set-aside requirements. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG, with a potential value of $7,036.80 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $10,555.20 firm fixed price delivery order is for the supply of 120 tablets of the prescription drug NUBEQA 300 mg. The award has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $9,367.94, is for the supply of Nubeqa 300 mg Tablet 120s, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 tablets of the medication NUBEQA 300 MG. The $3,518.40 firm fixed-price contract has a completion date of July 11, 2024. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of NUBEQA 300 MG Tablets. The $4,683.97 firm fixed price contract has a ceiling value and an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As a key supplier of medical commodities to the U.S. federal government, Amerisourcebergen leverages its extensive distribution network to provide a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a Delivery Order contract valued at $3,518.40 for the provision of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This contract has an ultimate completion date of August 5, 2024 and a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, is a prime contractor that holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,036.80 contract is for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has an ultimate completion date of June 27, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,641.98 firm-fixed-price contract is for the delivery of 120 tablets of the medication NUBEQA 300 MG. The contract has an ultimate completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...